Medicine
Chlorothiazide 500 mg/18 mL powder for injection
Chlorothiazide 500 mg/18 mL powder for injection is a generic prescription medicine for intravenous use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store lyophilized powder at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Chlorothiazide
- Brand
- Sold under the generic name
- Strength
- 500 mg/18 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial and 5 more
- Manufacturers
- Gland PharmaIndiaSun Pharmaceutical IndustriesIndiaFresenius KabiSagent PharmaceuticalsAmerican Regent
- Origin register
- US FDA, United States
- Storage
- Store lyophilized powder at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03AA04 Chlorothiazide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 October 2009
- Identifiers
- RxCUI 484152DailyMed set ID 850960a3-9fe2-4999-81eb-b0ae9ba011bc, 82dd0bdd-e6bd-48ea-8f58-c8bf71bbfe2c, bf921935-9740-458e-b786-69f76d8ad139 +5NDC 0517-1820, 25021-305, 68083-614 +2Application ANDA202561, ANDA202462, ANDA218630 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 18 mL in 1 vial | 68083-614-01 | Gland PharmaIndia | 3 October 2024 |
| 1 vial, single-dose in 1 carton / 18 mL in 1 vial, single-dose | 47335-330-40 | Sun Pharmaceutical IndustriesIndia | 25 August 2016 |
| 1 vial in 1 box / 18 mL in 1 vial | 63323-658-20 | Fresenius Kabi | 21 October 2009 |
| 1 vial in 1 box / 18 mL in 1 vial | 63323-658-27 | Fresenius Kabi | 21 October 2009 |
| 1 vial in 1 box / 18 mL in 1 vial | 63323-658-94 | Fresenius Kabi | 21 October 2009 |
| 1 vial in 1 carton / 18 mL in 1 vial | 25021-305-20 | Sagent Pharmaceuticals | 12 October 2015 |
| 1 vial in 1 carton / 18 mL in 1 vial | 25021-305-66 | Sagent Pharmaceuticals | 15 December 2019 |
| 1 vial in 1 carton / 18 mL in 1 vial | 0517-1820-01 | American Regent | 1 April 2015 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 September 1958 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Chlorothiazide
Clinical summary
Chlorothiazide is a thiazide diuretic indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy, among other approved uses. MedsAcross supplies Chlorothiazide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ChlorothiazideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DIURIL prescribing information (Salix Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Chlorothiazide 500 mg/18 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.